Source: The Pharmacogenomics Journal. Unidade: FMRP
Subjects: DISFUNÇÃO ERÉTIL, POLIMORFISMO, FARMACOGENÉTICA
ABNT
MUNIZ, J. J. et al. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. The Pharmacogenomics Journal, v. 3, n. 3, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.49. Acesso em: 27 abr. 2024.APA
Muniz, J. J., Lacchini, R., Rinaldi, T. O., Nobre, Y. T. D. A., Cologna, A. J., Martins, A. C. P., & Tanus-Santos, J. E. (2011). Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. The Pharmacogenomics Journal, 3( 3). doi:10.1038/tpj.2011.49NLM
Muniz JJ, Lacchini R, Rinaldi TO, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2024 abr. 27 ] Available from: https://doi.org/10.1038/tpj.2011.49Vancouver
Muniz JJ, Lacchini R, Rinaldi TO, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2024 abr. 27 ] Available from: https://doi.org/10.1038/tpj.2011.49